UK AI Firm Quantexa, Mersey Care NHS Foundation Trust and The University of Liverpool’s
Civic Health Innovation Labs Partner to Create a Groundbreaking Global AI Hub for Health and Social Care, in Liverpool
The University of Liverpool’s Civic Health Innovation Labs (CHIL) and partners will use a £4.9 million award from the Office for Life Sciences (OLS) to make better, quicker decisions from NHS Integrated Care System data. This will improve services for patients and communities, with a focus on mental health.
LONDON, EMBARGOED UNTIL 08:00AM GMT 18th March 2024 – Today, Quantexa, the global leader in Decision Intelligence (DI) solutions for the public and private sectors announced that its Decision Intelligence Platform will be adopted by the University of Liverpool’s Civic Health Innovation Labs (CHIL) and Mersey Care NHS Foundation Trust, one of the largest trusts providing physical health and mental health services in the Northwest, serving more than 1.4 million people.
The deployment and further development of Quantexa’s decision intelligence technology for health & social care comes as the CHIL announces £4.9 million in funding from the Office for Life Sciences (OLS) for a ‘Data-Action Accelerator’ project – a technology innovation engine for NHS Cheshire & Merseyside’s Data into Action Programme in partnership with CHIL.
Based within CHIL is the Mental Health Research for Innovation Centre (M-RIC), a partnership between Mersey Care NHS Foundation Trust and the University of Liverpool to tackle global challenges in mental health including increasing levels of illness.
Quantexa is now a core AI partner in M-RIC’s work. It will support in building a trusted data foundation to develop better drug and digital therapies, as well as to better co-ordinate care services.
Quantexa – soon to be co-located with CHIL following the opening of its first UK regional delivery hub team in Q2 2024 - will work with the University of Liverpool and NHS innovators to harness AI-enabled Decision Intelligence technology. This collaboration will help connect multiple data sources into a trusted data foundation that continually equips researchers, care teams, and patients to access, co-create and benefit from mental health research. Quantexa will be working alongside teams from the University of Liverpool, NHS Cheshire and Merseyside Integrated Care Board, and Mersey Care NHS Foundation Trust.
As part of this ongoing effort, Quantexa is supporting the creation of local jobs across engineering and product focused research and development roles. This investment will further establish Quantexa as a key member of the health and life sciences ecosystem in Liverpool and will drive forward its commitment to co-create with the NHS, government organisations, and the private sector to support in delivering data and analytics solutions that meet the healthcare sector’s objectives.
Vishal Marria, CEO of Quantexa said, “Quantexa’s vision is to work with university and NHS partners to address global current challenges in UK care programmes. Thanks to this OLS funding we can collaborate with M-RIC to improve care by making contextual data more accessible to providers and patients. Our investment into the Northwest region to support Mersey Care, wider NHS partners and the University of Liverpool is an important step towards supporting clinicians, caregivers, and patients with the right information to achieve better patient outcomes. Liverpool currently has one of the highest levels of mental health cases in the UK. This program has the potential to make a significant impact on under-served communities across the UK.”
Professor Iain Buchan, Director of CHIL, W.H. Duncan Chair in Public Health Systems and Associate Pro Vice Chancellor for Innovation, University of Liverpool said: “Our partnership with Quantexa Mersey Care, and the wider NHS Cheshire & Merseyside Integrated Care System, supported by the Office for Life Sciences, allows us to bring forward patient benefits from data and AI technologies. We are focusing on the global challenge of rising mental health conditions, which hits the most disadvantaged members of society hardest. As mental and physical health conditions are deeply intertwined, especially in deprived areas like Liverpool, our work will underpin actions to improve patient journeys across whole systems of health and social care – establishing Liverpool as a global hub for health systems AI.”
Professor Joe Rafferty, Chief Executive of Mersey Care NHS Foundation Trust said: “Mental health is a crucial component of overall wellbeing, but many people face barriers to accessing and receiving adequate care, especially in underserved areas. Our aim is to improve mental healthcare and treatments through advancing our understanding of how mental, physical and social conditions are interlinked and developing innovative research that brings together our service users with clinicians, academia & industry. Working with partners such as Quantexa, alongside our colleagues in the University of Liverpool, we can use data and AI to achieve better quality care for patients with mental health needs, and ultimately, better health outcomes and wellbeing for all.”
Quantexa remains committed to collaborating with the NHS, government organisations and the private sector to support the healthcare sector’s objectives through the ethical use of data and AI.
The University of Liverpool’s Civic Health Innovation Labs (CHIL) and partners will use a £4.9 million award from the Office for Life Sciences (OLS) to make better, quicker decisions from NHS Integrated Care System data. This will improve services for patients and communities, with a focus on mental health.
LONDON, EMBARGOED UNTIL 08:00AM GMT 18th March 2024 – Today, Quantexa, the global leader in Decision Intelligence (DI) solutions for the public and private sectors announced that its Decision Intelligence Platform will be adopted by the University of Liverpool’s Civic Health Innovation Labs (CHIL) and Mersey Care NHS Foundation Trust, one of the largest trusts providing physical health and mental health services in the Northwest, serving more than 1.4 million people.
The deployment and further development of Quantexa’s decision intelligence technology for health & social care comes as the CHIL announces £4.9 million in funding from the Office for Life Sciences (OLS) for a ‘Data-Action Accelerator’ project – a technology innovation engine for NHS Cheshire & Merseyside’s Data into Action Programme in partnership with CHIL.
Based within CHIL is the Mental Health Research for Innovation Centre (M-RIC), a partnership between Mersey Care NHS Foundation Trust and the University of Liverpool to tackle global challenges in mental health including increasing levels of illness.
Quantexa is now a core AI partner in M-RIC’s work. It will support in building a trusted data foundation to develop better drug and digital therapies, as well as to better co-ordinate care services.
Quantexa – soon to be co-located with CHIL following the opening of its first UK regional delivery hub team in Q2 2024 - will work with the University of Liverpool and NHS innovators to harness AI-enabled Decision Intelligence technology. This collaboration will help connect multiple data sources into a trusted data foundation that continually equips researchers, care teams, and patients to access, co-create and benefit from mental health research. Quantexa will be working alongside teams from the University of Liverpool, NHS Cheshire and Merseyside Integrated Care Board, and Mersey Care NHS Foundation Trust.
As part of this ongoing effort, Quantexa is supporting the creation of local jobs across engineering and product focused research and development roles. This investment will further establish Quantexa as a key member of the health and life sciences ecosystem in Liverpool and will drive forward its commitment to co-create with the NHS, government organisations, and the private sector to support in delivering data and analytics solutions that meet the healthcare sector’s objectives.
Vishal Marria, CEO of Quantexa said, “Quantexa’s vision is to work with university and NHS partners to address global current challenges in UK care programmes. Thanks to this OLS funding we can collaborate with M-RIC to improve care by making contextual data more accessible to providers and patients. Our investment into the Northwest region to support Mersey Care, wider NHS partners and the University of Liverpool is an important step towards supporting clinicians, caregivers, and patients with the right information to achieve better patient outcomes. Liverpool currently has one of the highest levels of mental health cases in the UK. This program has the potential to make a significant impact on under-served communities across the UK.”
Professor Iain Buchan, Director of CHIL, W.H. Duncan Chair in Public Health Systems and Associate Pro Vice Chancellor for Innovation, University of Liverpool said: “Our partnership with Quantexa Mersey Care, and the wider NHS Cheshire & Merseyside Integrated Care System, supported by the Office for Life Sciences, allows us to bring forward patient benefits from data and AI technologies. We are focusing on the global challenge of rising mental health conditions, which hits the most disadvantaged members of society hardest. As mental and physical health conditions are deeply intertwined, especially in deprived areas like Liverpool, our work will underpin actions to improve patient journeys across whole systems of health and social care – establishing Liverpool as a global hub for health systems AI.”
Professor Joe Rafferty, Chief Executive of Mersey Care NHS Foundation Trust said: “Mental health is a crucial component of overall wellbeing, but many people face barriers to accessing and receiving adequate care, especially in underserved areas. Our aim is to improve mental healthcare and treatments through advancing our understanding of how mental, physical and social conditions are interlinked and developing innovative research that brings together our service users with clinicians, academia & industry. Working with partners such as Quantexa, alongside our colleagues in the University of Liverpool, we can use data and AI to achieve better quality care for patients with mental health needs, and ultimately, better health outcomes and wellbeing for all.”
Quantexa remains committed to collaborating with the NHS, government organisations and the private sector to support the healthcare sector’s objectives through the ethical use of data and AI.